Physician profile
Mark A Dodson
NPI 1730297821
$1,255.73
in general payments reported to CMS, 2019-2025
20 companies · $288 in 2025
The $288 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $222 · 2021: $45.05 · 2022: $69.72 · 2023: $456 · 2024: $175 · 2025: $288.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $822 · Education: $96.81.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $822.41 |
| Education | $96.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $189.75 | 2024-2025 | |
| Novo Nordisk INC | $175.73 | 2023-2024 | Ozempic, Wegovy |
| Lilly USA, LLC | $159.94 | 2021-2023 | Mounjaro, Emgality |
| United Therapeutics Corporation | $136.36 | 2025 | Tyvaso |
| Idorsia Pharmaceuticals US INC | $106.26 | 2022-2023 | Quviviq |
| Actelion Pharmaceuticals US, INC. | $101.43 | 2019 | |
| Amgen INC. | $92.97 | 2019-2025 | Otezla, Repatha, Repatha |
| Abbott Laboratories | $59.26 | 2022-2024 | Proclaim, Eterna |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $43.11 | 2019-2023 | Trulance, Xifaxan |
| Csl Behring | $25.91 | 2025 | Kcentra |
| Radius Health, INC. | $22.76 | 2019 | |
| Abbvie INC. | $20.58 | 2023 | Vraylar |
| Merck Sharp & Dohme LLC | $19.04 | 2024 | Capvaxive |
| Astrazeneca Pharmaceuticals Lp | $18.13 | 2024 | Airsupra |
| Bausch Health US, LLC | $16.72 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $15.48 | 2023 | Xarelto |
| Glaxosmithkline, LLC. | $14.87 | 2022 | |
| Arbor Pharmaceuticals, INC. | $13.43 | 2021 | |
| Grifols USA, LLC | $12.22 | 2019 | |
| Shionogi INC | $11.78 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Dodson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.